Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular kinases and signaling proteins involved in oxidative stress and inflammation refers to a broad functional group of proteins that mediate cellular responses to harmful stimuli. This category includes several well-characterized pathways, such as the Mitogen-Activated Protein Kinase (MAPK) cascades, the Janus Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) pathway, and the Nuclear Factor-kappa B (NF-κB) system [1, 2]. These proteins act as sensors and transducers, converting signals from reactive oxygen species (ROS) or pro-inflammatory cytokines into specific cellular outcomes like gene expression, cell survival, or programmed cell death [1, 3]. Dysregulation of these signaling networks is a central feature of many chronic conditions, including rheumatoid arthritis, neurodegenerative diseases, and various cancers [2, 3]. While individual proteins within these pathways are highly validated therapeutic targets, the group as a whole is too heterogeneous to be considered a single target [4]. Therapeutic strategies often focus on inhibiting specific kinases or activating protective transcription factors like Nrf2 to restore cellular homeostasis [4]. However, the broad involvement of these proteins in normal physiology poses significant challenges for drug development, particularly regarding off-target effects and systemic toxicity [2, 4]. Citations: [1] Son, Y., et al. (2013) J Signal Transduct. [2] Liu, T., et al. (2017) Sig Transduct Target Ther. [3] Hu, X., et al. (2021) Sig Transduct Target Ther. [4] Ma, Q. (2013) Annu Rev Pharmacol Toxicol.
Inhibition of Janus kinases (JAKs), inhibition of Mitogen-activated protein kinase kinases (MEK), activation of Nuclear factor erythroid 2-related factor 2 (Nrf2), and inhibition of Nuclear factor-kappa B (NF-κB) activation.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular kinases and signaling proteins involved in oxidative stress and inflammation.